Categories: News

123Invent Inventor Develops Sensor-Activated Motorized Toilet (FJK-608)

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

PITTSBURGH, May 21, 2025 /PRNewswire/ — “I wanted to create a new toilet that can adapt to each individual user for optimal comfort and safety,” said an inventor, from Palm Bay, Fla., “so I invented the SAM- T. My smart design assists users in any stage of life.”

The invention provides an improved toilet designed to adapt to the individual user’s needs. In doing so, it increases comfort, convenience, safety, efficiency, and independence. It also eliminates the need to touch the toilet seat when raising or lowering it, and it ensures the toilet is clean for every use. The invention features an adjustable and innovative design that is easy to use, and it is ideal for individuals with physical disabilities or limited mobility, patients after surgery, etc.

The SAM- T is currently available for licensing or sale to manufacturers or marketers. For more information, visit www.sam-t.com. Or contact Dajaye Jenkins at 352-209-7740 or email info@sam-t.com.

CisionCision View original content to download multimedia:https://www.prnewswire.com/news-releases/123invent-inventor-develops-sensor-activated-motorized-toilet-fjk-608-302460140.html

SOURCE InventHelp

Staff

Recent Posts

Epic UGM 2025 Survival Guide: Insider Tips for Vendors, Storytellers, and Market Watchers

Black Book Research Marks Its 12th Year on the Ground in Verona with Independent, Vendor-Agnostic…

18 hours ago

rYojbaba Co., Ltd. Announces Closing of $5 Million Initial Public Offering of Japanese Common Shares

FUKUOKA, Japan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or…

21 hours ago

Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH

Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US Food and Drug…

21 hours ago

BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering

Offering Structured to Accelerate Streamex’s Operational Build-Out, Strategically Allocated with No WarrantsLos Angeles, CA, Aug.…

21 hours ago

Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001

CRANBERRY TOWNSHIP, Pa., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Jabez Biosciences, Inc., a clinical-stage biopharmaceutical…

21 hours ago